Welcome to Yeast Infection Solution
.... a sure-fire, 100% guaranteed, clinically researched system that is backed by 25,000+ hours of nutritional expertise for eliminating yeast infection for good. This is a very rare, highly unique and potently powerful candida healing system, which very few people even know exists.......more
Updates on Candida Candidiasis
Glenmark Generics gets US FDA nod for clotrimazole cream USP
Glenmark Generics Inc., USA, the subsidiary of Glenmark Generics Ltd has received final ANDA approval from the US FDA for clotrimazole cream USP, 1 per cent and will commence marketing and distribution of this product in the US market immediately.
Read more...Wyoming's First West Nile Virus Case Of 2010 Reported
An adult male from Goshen County has been reported to the Wyoming Department of Health as the state's first human West Nile virus (WNV) case for 2010. Most people infected with WNV never develop symptoms. Among those who become ill, symptoms include fever, headache, body aches, skin rash and swollen lymph nodes. A very small percentage of infected persons develop West Nile neuroinvasive disease ...
Read more...Perrigo confirms filing ANDA for generic Gynazole·1 cream with US FDA
Perrigo Company has filed with the US Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for butoconazole nitrate vaginal cream, 2 per cent and has notified KV Pharmaceutical Company, the owner of the New Drug Application (NDA) as well as FemmePharma, the listed owner of the patent, of its ANDA filing.
Read more...Perrigo files ANDA for butoconazole nitrate vaginal cream
Perrigo Company announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for butoconazole nitrate vaginal cream, 2% and that is has notified KV Pharmaceutical Company, the owner of the New Drug Application as well as FemmePharma, the listed owner of the patent, of its ANDA filing. KV is a licensee under the patent. Perrigo believes it is first-to ...
Read more...Perrigo Confirms Filing for Generic Version of Gynazole-1® Cream and Announcement of Patent Infringement Lawsuit by KV ...
ALLEGAN, Mich., July 30 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for butoconazole nitrate vaginal cream, 2% and that is has notified KV Pharmaceutical Company, the owner of the New Drug Application (NDA) as well as FemmePharma, the listed owner of the ...
Read more...
